Hepatic safety of buprenorphine in HIV-infected and uninfected patients with opioid use disorder: The role of HCV-infection

INTRODUCTION: Individuals with HIV and hepatitis C (HCV) infection, alcohol use disorder, or who are prescribed potentially hepatotoxic medications may be at increased risk for buprenorphine (BUP) associated hepatotoxicity. MATERIALS AND METHODS: We examined a cohort of HIV-infected and uninfected p...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Subst Abuse Treat
Prif Awduron: Tetrault, Jeanette M., Tate, Janet P., Edelman, E. Jennifer, Gordon, Adam J., Re, Vincent Lo, Lim, Joseph K., Rimland, David, Goulet, Joseph, Crystal, Stephen, Gaither, Julie R., Gibert, Cynthia L., Rodriguez-Barradas, Maria C., Fiellin, Lynn E., Bryant, Kendall, Justice, Amy C., Fiellin, David A.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2016
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4976086/
https://ncbi.nlm.nih.gov/pubmed/27431048
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsat.2016.06.002
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg